MDK seems to be involved in tumor cell communication through binding several of its receptors, including syndecan 1 (SDC1), SDC4, NCL, and LRP1, and MDK from tumors seems to bind to NCL on macrophages and lymphocytes, though the functional consequences have not been explored [162]. Here, NUCLEOLIN is linked to neoplasm.